Viewing nowLamiGuard Tablet (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.

MFDS item code 202001714 · Approved 2020.03.12 · Insurance code 678601670
Treatment of cutaneous fungal infections (tinea pedis, tinea corporis, etc.), onychomycosis, and tinea capitis
This medication is used for the treatment of dermatophyte infections and onychomycosis in adults, including athlete's foot, body ringworm, and groin ringworm. It is also effective for treating tinea capitis in children.
Administer 125 mg of terbinafine twice daily or 250 mg once daily. The duration of treatment varies according to the condition, as follows: 1) Dermatophytosis Tinea pedis (interdigital or plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris (jock itch): 2~4 weeks 2) Onychomycosis Treatment is generally given for 6 weeks~3 months. In infections of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. A treatment period of 3 months is usually sufficient for toenail infections, although some patients may require 6 months or longer. The treatment period may be longer in patients with slow nail growth. Patients with renal impairment Reduce the daily dose by 1/2 in patients with a creatinine clearance of less than 50 mL/min.
Administer to children 2 years of age and older. Administration is not recommended for children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of the infection, treatment should be given regularly and for the prescribed duration. Body weight under 20 kg (under 5 years of age): Administer 62.5 mg once daily. Because experience with its use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years of age): Administer 125 mg once daily. Body weight over 40 kg (over 12 years of age): Administer 250 mg once daily.
This drug should not be used in patients with chronic liver disease or active liver disease. Before taking this medication, it is essential to check liver health and perform regular liver function tests. If liver function levels increase during treatment, discontinue the medication immediately. If symptoms such as nausea, loss of appetite, fatigue, vomiting, pain in the upper right abdomen, jaundice of the skin or eyes, dark urine, or oily stools occur, inform a doctor immediately. This medication may cause serious problems with liver function, so careful monitoring is required. Patients allergic to this drug, or those with blood disorders, severe kidney dysfunction, children under 2 years old, and breastfeeding women should not take this drug. Patients with certain genetic disorders such as lactose intolerance should also avoid this medication. Patients with weak kidney function, elderly patients, and underweight children should use this medication with caution, and if severe rash or allergic reactions occur, discontinue use immediately. This medication can worsen symptoms in patients with skin diseases, so caution is necessary. During treatment, regular blood tests should be conducted in addition to monitoring liver function, and consult a doctor immediately if abnormal symptoms occur. This drug can cause side effects such as gastrointestinal disorders, headaches, taste disturbances, muscle pain, dizziness, and rashes, so inform your doctor if symptoms are severe. Be cautious when driving or operating machinery if experiencing dizziness. There may be interactions with other medications, so if you are taking other drugs, inform your doctor or pharmacist. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this drug, and breastfeeding women should discontinue nursing while taking this medication. Children and elderly individuals require special attention when taking this medication. In case of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may occur, and immediate medical assistance should be sought. Store this medication out of reach of children and avoid direct sunlight, keeping it at room temperature.
Persistent nausea, loss of appetite, fatigue, vomiting, upper abdominal pain, jaundice, dark urine, loose stools, biliary tract failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, lethargy, increased γ-GTP, increased AST/ALT, increased LDH, increased ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reactions, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasis-like rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, increased CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distention, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory abnormalities, sensory decrease, decreased attention, insomnia, increased BUN, increased urination, visual disturbances, tinnitus, anaphylactoid reactions, angioedema, systemic lupus erythematosus, increased serum total cholesterol, increased triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reactions, serum sickness-like reactions, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent anosmia, hyposmia, eosinophilia, drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to keep the storage temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness safely.
White round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.